Locking the Door to Leukocytes: Use of Integrin Inhibitors for the Treatment of Crohn’s Disease

Clinical Medicine Insights: Therapeutics - New Zealand
doi 10.4137/cmt.s4013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications


Related search